Stewart L. Fisher - Concepedia

Author

Stewart L. Fisher

Also Known As

Fisher, Stewart, Fisher, Stewart L., Henry G. Gilbert Nursery and Seed Trade Catalog Collection., S L Fisher, S. L Fisher, S. L. FISHER, S. L. Fisher, S.L. Fisher, Stewart Fisher, Stewart L Fisher

Publications

5.4K

Citations

H-Index

100

Concepts

All Affiliations

AstraZeneca (United States)Harvard University Broad Institute Massachusetts General Hospital C4 Therapeutics (United States)

About

Stewart L. Fisher is an author at AstraZeneca (United States) specializing in medicine, natural sciences, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	24	2.2K
2	Natural Sciences	14	14	898
3	Biochemistry	13	13	786
4	Engineering	3	3	298
5	Health Sciences	3	3	370

Stewart L. Fisher

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
Response of melanocortin–4 receptor–deficient mice to anorectic and orexigenic peptides Donald J. Marsh, Gunther Hollopeter, Dennis Huszar, Nature Genetics NeuropeptidesAppetite ControlMedicinePhysiologyImmunology	1999	545
Avibactam is a covalent, reversible, non–β-lactam β-lactamase inhibitor David E. Ehmann, Haris Jahić, Philip L. Ross, Proceedings of the National Academy of Sciences	2012	507
Kinetics of Avibactam Inhibition against Class A, C, and D β-Lactamases David E. Ehmann, Haris Jahić, Philip L. Ross, Journal of Biological Chemistry D β-LactamasesAntimicrobial ChemotherapyAvibactam InhibitionDrug ResistanceAntimicrobial Therapy	2013	348
The N-terminal Domain of RGS4 Confers Receptor-selective Inhibition of G Protein Signaling Weizhang Zeng, Xin Xu, Serguei Popov, Journal of Biological Chemistry	1998	233
Identification and functional analysis of novel human melanocortin-4 receptor variants. Wei Gu, Zhiguang Tu, Patrick W. Kleyn, Diabetes EngineeringMetabolic DisorderGeneticsImmunologyHuman Polymorphism	1999	193
Central infusion of melanocortin agonist MTII in rats: assessment of c-Fos expression and taste aversion Todd E. Thiele, Gertjan van Dijk, Keith A. Yagaloff, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology	1998	178
Translating slow-binding inhibition kinetics into cellular and in vivo effects Grant K. Walkup, Zhiping You, Philip L. Ross, Nature Chemical Biology Signal TransductionBiochemistryCell SignalingMedicineNatural Sciences	2015	148
Exploitation of structural and regulatory diversity in glutamate racemases T. Lundqvist, Stewart L. Fisher, Günther Kern, Nature Glutamate RacemasesNatural SciencesGeneticsGene StructureMolecular Biology	2007	138
A small-molecule allosteric inhibitor of Mycobacterium tuberculosis tryptophan synthase Samantha Wellington, Partha P. Nag, K. Michalska, Nature Chemical Biology Small-molecule Allosteric InhibitorTuberculosisMicrobiologyMedicineInhibitory Activity	2017	117
A conformational study of peptides with the general structure Ac-L-Xaa-Pro-D-Xaa-L-Xaa-NH2: spectroscopic evidence for a peptide with significant .beta.-turn character in water and in dimethyl sulfoxide Barbara Imperiali, Rex Moats, Stewart L. Fisher, Journal of the American Chemical Society	1992	114

Page 1